Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Intervalo de año de publicación
1.
Sci Rep ; 5: 9232, 2015 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-25782665

RESUMEN

It remains a challenge to differentiate human induced pluripotent stem cells (iPSCs) or embryonic stem (ES) cells to Purkinje cells. In this study, we derived iPSCs from human fibroblasts and directed the specification of iPSCs first to Purkinje progenitors, by adding Fgf2 and insulin to the embryoid bodies (EBs) in a time-sensitive manner, which activates the endogenous production of Wnt1 and Fgf8 from EBs that further patterned the cells towards a midbrain-hindbrain-boundary tissue identity. Neph3-positive human Purkinje progenitors were sorted out by using flow cytometry and cultured either alone or with granule cell precursors, in a 2-dimensional or 3-dimensional environment. However, Purkinje progenitors failed to mature further under above conditions. By co-culturing human Purkinje progenitors with rat cerebellar slices, we observed mature Purkinje-like cells with right morphology and marker expression patterns, which yet showed no appropriate membrane properties. Co-culture with human fetal cerebellar slices drove the progenitors to not only morphologically correct but also electrophysiologically functional Purkinje neurons. Neph3-posotive human cells could also survive transplantation into the cerebellum of newborn immunodeficient mice and differentiate to L7- and Calbindin-positive neurons. Obtaining mature human Purkinje cells in vitro has significant implications in studying the mechanisms of spinocerebellar ataxias and other cerebellar diseases.


Asunto(s)
Células Madre Pluripotentes Inducidas/citología , Células de Purkinje/citología , Animales , Técnicas de Cultivo de Célula , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Cerebelo/metabolismo , Cerebelo/patología , Técnicas de Cocultivo , Factor 2 de Crecimiento de Fibroblastos/farmacología , Humanos , Inmunoglobulinas/metabolismo , Inmunohistoquímica , Insulina/farmacología , Proteínas de la Membrana/metabolismo , Ratones , Ratones SCID , Microscopía Fluorescente , Neuronas/metabolismo , Células de Purkinje/metabolismo , Células de Purkinje/trasplante , Ratas , Trasplante Heterólogo , Alcaloides de Veratrum/farmacología
2.
Oncol Rep ; 33(3): 1207-14, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25572698

RESUMEN

Metastasis is the leading cause of death in lung cancer. Understanding the mechanisms underlying the process of metastasis is crucial for identifying novel anti-metastatic therapies. Studies indicate that the highly conserved developmental pathways, such as the Wnt and Notch signaling pathways, play important roles in the non-small cell lung cancer (NSCLC) tumorigenesis. However, the roles of both pathways in NSCLC metastasis are unclear. The present study aimed to investigate whether Wnt3a and Notch3, key components of the Wnt and Notch signaling pathways, respectively, regulate the metastatic abilities of NSCLC cells and whether there is some relationship during these regulatory events. Here, we observed that Wnt3a treatment upregulated, not only the protein expression of Notch3, but also the mRNA expression of Notch3 and its downstream genes, HES1 and HEYL. In addition, Wnt3a promoted cell invasion and anchorage-independent growth. Meanwhile, Wnt3a treatment caused epithelial­mesenchymal transition (EMT)-like morphological changes and F-actin reorganization. The western blotting data showed that Wnt3a treatment decreased the expression of E-cadherin and increased the expression of N-cadherin and vimentin. Compared with Wnt3a treatment, Notch3 shRNA transfection had opposite effects. Furthermore, Notch3 shRNA weakened the effects of Wnt3a treatment on the in vitro cell invasion and EMT. Overall, these observations suggest that Wnt3a and Notch3 may promote the metastasis of NSCLC and Notch3 upregulation is required for the Wnt3a mediated increased metastatic abilities of NSCLC.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/patología , Neoplasias Pulmonares/patología , Metástasis de la Neoplasia/patología , Receptores Notch/genética , Proteína Wnt3A/genética , Actinas/metabolismo , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/biosíntesis , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/genética , Cadherinas/biosíntesis , Carcinoma de Pulmón de Células no Pequeñas/genética , Línea Celular Tumoral , Transición Epitelial-Mesenquimal/genética , Proteínas de Homeodominio/biosíntesis , Proteínas de Homeodominio/genética , Humanos , Neoplasias Pulmonares/genética , Invasividad Neoplásica/genética , Metástasis de la Neoplasia/genética , Interferencia de ARN , ARN Mensajero/biosíntesis , ARN Interferente Pequeño , Receptor Notch3 , Receptores Notch/biosíntesis , Proteínas Represoras/biosíntesis , Proteínas Represoras/genética , Factor de Transcripción HES-1 , Activación Transcripcional , Regulación hacia Arriba , Vimentina/biosíntesis , Vía de Señalización Wnt/genética
3.
Cell Discov ; 1: 15012, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-27462412

RESUMEN

Autologous dopamine (DA) neurons are a new cell source for replacement therapy of Parkinson's disease (PD). In this study, we tested the safety and efficacy of autologous induced pluripotent stem cell (iPSC)-derived DA cells for treatment of a cynomolgus monkey PD model. Monkey bone marrow mesenchymal cells were isolated and induced to iPSCs, followed by differentiation into DA cells using a method with high efficiency. Autologous DA cells were introduced into the brain of a cynomolgus monkey PD model without immunosuppression; three PD monkeys that had received no grafts served as controls. The PD monkey that had received autologous grafts experienced behavioral improvement compared with that of controls. Histological analysis revealed no overgrowth of grafts and a significant number of surviving A9 region-specific graft-derived DA neurons. The study provided a proof-of-principle to employ iPSC-derived autologous DA cells for PD treatment using a nonhuman primate PD model.

4.
Stem Cell Res ; 14(1): 1-9, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25460246

RESUMEN

Lmx1a plays a central role in the specification of dopaminergic (DA) neurons, which potentially could be employed as a key factor for trans-differentiation to DA neurons. In our previous study, we have converted somatic cells directly into neural stem cell-like cells, namely induced neural stem cells (iNSCs), which further can be differentiated into subtypes of neurons and glia in vitro. In the present study, we continued to test whether these iNSCs have therapeutic effects when transplanted into a mouse model of Parkinson's disease (PD), especially when Lmx1a was introduced into these iNSCs under a Nestin enhancer. iNSCs that over-expressed Lmx1a (iNSC-Lmx1a) gave rise to an increased yield of dopaminergic neurons and secreted a higher level of dopamine in vitro. When transplanted into mouse models of PD, both groups of mice showed decreased ipsilateral rotations; yet mice that received iNSC-Lmx1a vs. iNSC-GFP exhibited better recovery. Although few iNSCs survived 11weeks after transplantation, the improved motor performance in iNSC-Lmx1a group did correlate with a greater tyrosine hydroxylase (TH) signal abundance in the lesioned area of striatum, suggesting that iNSCs may have worked through a non-autonomous manner to enhance the functions of remaining endogenous dopaminergic neurons in brain.


Asunto(s)
Proteínas con Homeodominio LIM/metabolismo , Células-Madre Neurales/trasplante , Enfermedad de Parkinson/terapia , Factores de Transcripción/metabolismo , Animales , Conducta Animal , Diferenciación Celular , Línea Celular , Cuerpo Estriado/metabolismo , Modelos Animales de Enfermedad , Neuronas Dopaminérgicas/metabolismo , Neuronas Dopaminérgicas/patología , Elementos de Facilitación Genéticos/genética , Proteínas con Homeodominio LIM/genética , Masculino , Ratones , Ratones Endogámicos C57BL , Nestina/genética , Células-Madre Neurales/citología , Células-Madre Neurales/metabolismo , Enfermedad de Parkinson/patología , Factores de Transcripción/genética , Tirosina 3-Monooxigenasa/metabolismo
5.
Artículo en Inglés | MEDLINE | ID: mdl-25531303

RESUMEN

BACKGROUND: Mast cells (MCs) in the nasal respiratory mucosa (NRM) play a triggering role in the pathogenesis of allergic rhinitis (AR). Recent research evidence in mouse models of AR suggests an underlying MC-related allergic response in mouse nasal olfactory mucosa (NOM). OBJECTIVE: We sought to investigate the phenotypic characteristics of nasal MCs in a mouse model of AR. METHODS: By MC-specific staining and immunohistochemistry, we analyzed the subset, protease and IgE-binding phenotypes of nasal MCs in ovalbumin (OVA)-sensitized unchallenged and challenged mice. RESULTS: In OVA-sensitized challenged mice, increased serum OVA-specific IgE levels (p < 0.001) and eosinophil infiltration confirmed AR induction. In addition to constitutive connective tissue MCs, mucosal MCs were induced in NRM and NOM of OVA-sensitized challenged mice. Connective tissue MCs and mucosal MCs in mouse NRM and NOM were positive for mouse MC protease-1, -4, -5, -6, -7 and carboxypeptidase-A3. In line with MCs in NRM, there were increased numbers (p = 0.019) and proportions (p = 0.027) of MCs with surface-bound IgE in NOM of OVA-sensitized challenged mice. CONCLUSION: In the setting of AR, MCs in mouse NOM exhibit the same subset, protease and IgE-binding phenotypes as MCs in mouse NRM.


Asunto(s)
Mastocitos/inmunología , Mucosa Nasal/citología , Rinitis Alérgica/inmunología , Animales , Carboxipeptidasas/metabolismo , Modelos Animales de Enfermedad , Endopeptidasas/metabolismo , Ensayo de Inmunoadsorción Enzimática , Eosinófilos/inmunología , Femenino , Técnicas para Inmunoenzimas , Inmunoglobulina E/sangre , Mastocitos/metabolismo , Ratones , Ratones Endogámicos BALB C , Fenotipo , Rinitis Alérgica/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA